Clinic-based Translational Research Cohort/ Clinical Trial Immunology Core Lab (Sinclair) Basic Immunology Lab (McCune) Virology Core Lab (Liegler) Basic.

Slides:

Advertisements

Similar presentations

Specimen Model Project: Requirements from Clinical Genomics Mukesh Sharma Washington University Medical School St. Louis October 2010 WG meeting.

Advertisements

The Diagnostic Laboratory ……the ideal system……. Molecular Genetics Diagnostic Laboratory Exciting area of medical pathology Need to continually up-date.

Follow-up after training and supportive supervision The IMAI District Coordinator Course.

East Africa DATA East African IeDEA PI Meeting Zanzibar, Tanzania May 4, 2010 Beverly Musick Regional Data Manager.

Evaluating residual HIV reservoirs Background or why is this important? What can be measured? Where should we measure it? Conclusions.

HLA-B57 does not fully explain the ability of HIV controllers to clear HCV infection Alice K. Asher 1, RN, MS; Glenn-Milo Santos 1, MPH; Jennifer Evans,

Funding of Cohort Studies Diana Finzi, Ph.D. Chief, Pathogenesis and Basic Research Branch Division of AIDS National Institutes of Health Bethesda, Maryland,

The role of HIV infection and Co-infections in Serious Non-AIDS Events Peter W. Hunt, M.D Associate Professor of Medicine, UCSF.

John Aberle-Grasse CDC GAP Strategies for Building National-Scale Longitudinal Patient Monitoring Systems for HIV Treatment and Care Lusaka, October 2-5,

Why is inflammation elevated in treated HIV infection and why does it matter? Steven G. Deeks Professor of Medicine University of California, San Francisco.

University of Pittsburgh Department of Biomedical Informatics Healthcare institutions have established local clinical data research repositories to enable.

Implementing OpenMRS Medical Record System in an AIDS treatment program in Uganda Daniel Kayiwa.

Role of Antiretroviral Therapy, Viral Replication, and HIV Infection in Atherosclerosis Priscilla Y. Hsue, Peter W. Hunt, Jeffrey N. Martin, Amanda Schnell,

“Getting to Zero: Thailand’s Experience with E-MTCT” Petchsri Sirinirund Advisor on HIV/AIDS Policy and Programme Department of Disease Control, Thailand.

Hepatitis and Liver Cancer A National Strategy for Prevention and Control of Hepatitis B and C.

Discovery of New Antibodies Against HIV A Case Study of a Global Partnership Prof. Omu Anzala Program Director Kenya AIDS Vaccine Initiative (KAVI) Department.

University of California, San Francisco San Francisco General Hospital

Patients in routine HIV clinical care at-risk for potentially transmitting HIV in the “test and treat” era of HIV prevention Crane, HM, Mimiaga, M, Feldman,

Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.

Cell- and Tissue-based Measures of Viral Persistence Are Associated with Immune Activation and PD-1-Expressing CD4+ T cells H Hatano 1, V Jain 1, PW Hunt.

Highlights of MACS and WIHS Protocol and Cohorts Lisa Jacobson Stephen Gange May 25, 2005 Not for distribution or publication outside the Multicenter AIDS.

Secretary’s Advisory Committee on Heritable Disorders of Newborns and Children September 22, 2011 Newborn Screening Translational Research Network (NBSTRN)

HIV Patient ART Monitoring Meeting: International Conference Centre, Geneva March 2004 Defining the variables.

Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.

Effectiveness of Micronutrient-rich Lipid Nutrient Supplements in Delaying Clinical Progression of HIV in Malawian Adults Heidi Sandige, MD.

TB DIAGNOSTICS R&D: Not Just Technology Peter Mehlape, General Manager GBC Southern Africa Conference 11th October 2010, Johannesburg BD Experience with.

INDEPTH NETWORK – UPDATE & CURRENT CHALLENGES SEACO, November 2011, Johor, Ruth Bonita (acknowledgements to David Ross, Chair INDEPTH SAC)

My Own Health Report: Case Study for Pragmatic Research Marcia Ory Texas A&M Health Science Center Presentation at: CPRRN Annual Grantee Meeting October.

Case Series of HIV-infected children with Bacillus Calmette-Guérin Vaccine Related Lymphadenopathy in Lilongwe, Malawi John Midturi Kazembe, PN., Schutze,

1 Diagnosis of HIV Infection in Children HAIVN Harvard Medical School AIDS Initiatives in Vietnam.

The Immunologic Efficacy of Antiretroviral Therapy among HIV-infected Patients in North America and Africa Elvin Geng* 1, Eric Vittinghoff 1, Jean Nachega.

Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.

A single nucleotide polymorphism in CYP2B6 leads to >3-fold increases in efavirenz concentrations in intensive pharmacokinetic curves and hair samples.

Peter W. Hunt, MD Associate Professor of Medicine in Residence

The Positive Predictive Value of World Health Organization (WHO) Immunologic Criteria for Treatment Failure in a Public Health Antiretroviral Delivery.

Ilesh V. Jani, MD PhD Instituto Nacional de Saúde Maputo, Mozambique.

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 The Infectious Diseases Institute Care and Research Initiatives Dr Alex G Coutinho.

Factors Associated with Survival in HIV-Infected African Patients on Antiretroviral Therapy: The Impact of a Sampling-Based Approach to Address Losses.

The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.

Providing Treatment, Restoring Hope Program Updates Dr. Robb Sheneberger, MD University of Maryland School of Medicine Track 1.0 Implementers Meeting Dar.

Retention in Care among HIV-infected Patients Receiving Antiretroviral Therapy in Africa: Estimation via a Sampling-based Approach Elvin Geng 1, David.

Implementing an Electronic Medical Record System in a Rural HIV Clinic in Uganda Nicholas Musinguzi 1, Elvin H. Geng 2, David R. Bangsberg 3, Nneka I.

Failure to Initiate ART, Loss to Follow-up and Mortality among HIV-infected Patients during the pre-ART period in Uganda Elvin H. Geng 1, Winnie Muyindike.

Evaluating the Use of HIV Surveillance Data for Initiating Partner Services in Houston, Texas, US 2012 International AIDS Conference Washington, D.C. Shirley.

Retention in care and connection to care among HIV-infected patients receiving ART n Africa: Estimation via a sampling-based approach Elvin Geng 1, David.

Sub module 3 Pre-ART and ART registers. Purpose of registers Key individual information for: Facilitating patient management by the identification of.

EMTCT in Europe. MTCT rates, UK and Ireland, CROI 2007 Poster 761, Townsend et al diagnosed women, Low rates of MTCT from diagnosed.

Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.

Integrated Community HIV Testing Campaigns: Leveraging HIV infrastructure for non- communicable diseases July 23, 2012 Gabriel Chamie, Dalsone Kwarisiima,

Conclusions Materials and Methods Background Objectives HIV-1 RNA is the most significant determinant of cervical HIV-1 shedding. Shedding has also been.

PMTCT - The Platform for integrating HIV/AIDS Services in the MCH Clinic. Bola Oyeledun, MD, MPH Track 1.0 Partners Meeting Washington DC. August 2008.

Integrating the Healthcare Enterprise Retrieve Information for Display (RID) Integration Profile Ellie Avraham Kodak Health Imaging IHE IT Infrastructure.

Integrating the Healthcare Enterprise Update on IHE-Laboratory Charles Parisot General Electric Medical Systems IT.

HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.

The “rare patient” Julia del Amo ISCIII, Madrid, Spain.

National Immunization Conference March 2006 Integrating Immunization Registries with a Disease Surveillance and Management System Michael L. Popovich

1 Predictors of Immunological Failure Among Adult Patients Receiving ART at an urban, HIV Clinic in Uganda Dr. Muhumuza Simon (M.D, MPH) Mulago-Mbarara.

11/21/2014 CFAR Mentoring Core Facilities at UCSF and Beyond Teri Liegler, PhD Director ARI-UCSF Laboratory of Clinical Virology CFAR Virology Core Laboratory.

The impact of treatment duration on defective and expanded identical HIV genomes in T cell subsets from peripheral blood and tissues Eunok Lee.

Prolonged HIV-1 Remission and Viral Rebound in an Individual Treated During Hyperacute Infection Timothy Henrich, Hiroyu Hatano, Alison Hill, Oliver Bacon,

New WHO Guidelines on Person centred monitoring

Differentiated Monitoring & Evaluation

Emory University School of Medicine Department of Medicine

UCSF Core Facilities Enterprise

Clinic-based Translational Research

Specimen Processing and Analytical Nexus

Primary Care Performance Measurement and Reporting

Clinic-based Translational Research

Core Facilities at UCSF and Beyond

Lesson 3: The HCV Care Continuum

Presentation transcript:

Clinic-based Translational Research Cohort/ Clinical Trial Immunology Core Lab (Sinclair) Basic Immunology Lab (McCune) Virology Core Lab (Liegler) Basic Virology Lab (Wong) Cardiology (Hsue) GI (Somsouk) Neurology (Price)

Productivity Mostly Attributable to Data and Biological Specimens from the Cohorts SCOPEUARTOISS Clinic No. of subjects ,087 LocationSan FranciscoMbarara, Uganda Cohort typeDynamicFixedDynamic Entry Criteria Demand-driven collection of both prototypical & rare clinical phenotypes Consecutive ART starters at a prototypical municipal ART clinic All patients at a prototypical municipal ART clinic Paper-based measurements Research-dedicated During course of clinical care Biologic specimens Serum, plasma, PBMCs, saliva -- Follow-up4 months Clinically-driven Special procedures Gut & lymph node biopsies, apheresis Real time adherence monitoring Active tracking of drop outs

Clinical Cohorts SCOPE: Chronically HIV-infected patients Enriched for “extreme phenotypes” (elite controllers, viremic non- progressors, immunologic non-responders, etc). Key Faculty: Steve Deeks, Jeff Martin, Peter Hunt, Hiroyu Hatano OPTIONS: Recently/Acutely HIV-infected patients Boutique Cohorts: Transmission pairs, Highly exposed HIV- uninfected patients Key Faculty: Rick Hecht, Chris Pilcher WIHS: Multi-center cohort of HIV-infected women and risk-matched HIV-negative controls Key Faculty: Ruth Greenblatt, Monica Gandhi, Phyllis Tien

Domestic Cohort Linkages

International Cohort Linkages ISS Clinic Cohort UARTO Central Africa

Other Research Networks ACTG (AIDS Clinical Trials Group) Marion Peters (Hepatitis TSG Chair) Diane Havlir (TB TSG Vice Chair) Peter Hunt (Inflammation/End-organ Disease Vice Chair) CNICS (CFAR Network of Integrated Clinical Systems) Linked electronic medical records across multiple HIV clinics Specimens available to link biomarkers to rare clinical outcomes Key Faculty: Elvin Geng, Steve Deeks, Peter Hunt, Jeff Martin

Core Metrics: * including submitted ItemNumber Projects Total144 International 33 Users Total205 UCSF CFAR 69 Other CFARs 57 Non-CFAR 79 Early Stage Investigators38 Publications*60 Conference Presentations58

Real time inventory Rapid distribution Specimen Type No. Unique Timepoints Plasma2080 Serum450 Viable PBMC947 Non-viable PBMC : 48 separate specimen shipments to investigators

Innovation: Linkage to CNICS Specimen Repository March 25, 1987 to present 8 contributing sites - CWRU- Fenway - JHU- UAB - UCSD- UCSF - UNC - UW 661,880 aliquots - from 77,819 unique timepoints -- from 11,414 HIV-infected patients